地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18372041646
传真:17754422825
邮箱:sales@amyjet.com

艾美捷科技代理Screenfect品牌全系列产品
ScreenFect GmbH成立于2012年,是一家专注于细胞转染技术创新的德国生物技术公司。ScreenFect®转染试剂是该公司的核心产品,是依托组合化学方法构建独特化学文库,通过高通量细胞筛选平台高效开发的转染试剂。ScreenFect®转染试剂适用于多种核酸分子(包括pDNA、siRNA、mRNA、miRNA)的单转染与共转染,在难转染细胞(如原代细胞、干细胞)中具有优异性能。

▎ScreenFect®转染试剂
● ScreenFect®A是一款通用型转染试剂,适用于pDNA、siRNA、mRNA的递送以及共转染实验,可广泛应用于多种细胞系(如HEK、HeLa、MEF)及部分原代细胞系。高效转染:在96孔板中仅需低于100ng DNA即可实现高转染效率。
● ScreenFect®siRN 是转染小干扰RNA双链体的理想选择,适用于HEK、HeLa、MEF等标准哺乳动物细胞系及多种原代细胞系。
● ScreenFect®mRNA是专为mRNA转染优化的高效试剂。
● ScreenFect®A-plus是一款多功能增强型转染试剂,适用于pDNA、siRNA、mRNA的转染及共转染实验,在几乎所有细胞系(包括难转染细胞)中均能实现高效转染。
| 货号 | 品名 | 规格 | Dilution buffer |
| S-3001 | ScreenFect®A | 1 mL | 50 mL |
| S-3001-2 | ScreenFect®A | 0,2 mL | 10 mL |
| S-4001 | ScreenFect®siRNA | 1 mL | 50 mL |
| S-4001-2 | ScreenFect®siRNA | 0,2 mL | 10 mL |
| S-5001 | ScreenFect®mRNA | 1 mL | 50 mL |
| S-5001-2 | ScreenFect®mRNA | 0,2 mL | 10 mL |
| S-6001 | ScreenFect®A-plus | 1 mL | 50 mL |
| S-6001-2 | ScreenFect®A-plus | 0,2 mL | 10 mL |
| S-2001-2 | ScreenFect Buffer | 10 mL | - |
| S-2001 | ScreenFect Buffer | 50 mL | - |
ScreenFect®转染试剂具有以下特点:
● 低细胞毒性:显著降低对细胞活性的影响
● 省时一步法:支持细胞铺板与转染同步操作(即用型方案)
● 快速优化:针对新用户/新细胞系提供简易优化流程
● 血清兼容性:无需更换培养基,可直接在含血清环境下使用
● 无动物源成分:杜绝动物源性物质污染风险
● 高通量适用:完美适配大规模筛选实验需求
▎ScreenFect®UP-293
ScreenFect®UP-293 是一款专为高效生产抗体及蛋白设计的转染试剂,适用于HEK 293-F悬浮细胞体系。配合ScreenFect®Booster增效剂使用,可最大化提升悬浮细胞中的蛋白产量。
| 产品编号 | 悬浮培养体积 | 组分 | 组分体积 |
| S-8010-0.5L | 0.5 litre | ScreenFect®UP-293 | 1 mL |
| ScreenFect®Booster | 2.5 mL | ||
| ScreenFect®Buffer | 35 mL | ||
| S-8010-1L | 1 litre | ScreenFect®UP-293 | 2 mL |
| ScreenFect®Booster | 5 mL | ||
| ScreenFect®Buffer | 70 mL | ||
| S-8010-10L | 10 litres | ScreenFect®UP-293 | 20 mL |
| ScreenFect®Booster | 50 mL | ||
| ScreenFect®Buffer | 700 mL | ||
| S-8010-50L | 50 litres | ScreenFect®UP-293 | 100 mL |
| ScreenFect®Booster | 250 mL | ||
| ScreenFect®Buffer | 3.5 L |
▎ScreenFect®Booster
在完成HEK293F悬浮细胞的ScreenFect®UP-293转染后,于转染后16小时添加ScreenFect®Booster增效剂,可显著提升蛋白产量。该增效剂含特定复合组分,通过重编程细胞代谢路径(从增殖模式转向蛋白合成模式),从而高效提升大多数目标蛋白的表达水平。
| 货号 | 品名 | 规格 |
| S-2001-2 | ScreenFect Buffer | 10 mL |
| S-2001 | ScreenFect Buffer | 50 mL |
invivoCrown IV0115替换BioXCell BE0060
invivoCrown IV0110替换BioXCell BE0058
invivoCrown IV0120替换BioXCell BE0015-1

GLYCON Biochemicals GmbH公司位于德国Luckenwalde,是一家专门从事特种糖类化合物研发、生产的公司,除了高品质的目录产品,GLYCON Biochemicals GmbH公司还承接定制合成生产,包括糖及其衍生物、糖复合物等,可以进行1-10kg规模的生产。
GLYCON emphasises research and development, combining innovative thinking with the necessities of the market. We offer the flexible service and modern equipment needed to produce gram and kilogram quantities of fine and pharmaceutical chemicals.
Custom synthesis and service
- carbohydrates and their derivatives
- glycoconjugates
- small scale production (1 g - 10 kg)
- chromatography on 25 L columns
主要产品类型
(1)non ionic detergents
alkyl glucopyranoside
alkyl maltoside
alkyl thio-glycosides
mega
alkylethyleneglycol
other products
(2)ionic detergents
cholesterols (chaps, chapso)
alkylphosphocholine
(3)sugar phosphates
(4)carbohydrates
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://plant.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="GLYCON Biochemicals GmbH"> GLYCON Biochemicals GmbH
invivoCrown IV0112替换BioXCell BE0131
invivoCrown IV0120替换BioXCell BE0015-1
invivoCrown IV0114替换BioXCell BE0213

Innovative Research of America(IRA) 是一家致力研发于药物定量定时缓释系统的专业化公司,又称Matrix-Driven Delivery (MDD) 给药系统。该给药系统由一个可生物吸收的基质组成,含有定量可控的活性给药成分,可以以设定的剂量在一定时间范围内进行给药。
Since it is not easy to administer drugs and hormones orally to research animals, several delivery methods have been devised as alternatives. However, most scientists continue to labor with unreliable injectables to conduct their research.
Matrix-Driven Delivery (MDD) Pellet(MDD片剂)的优势
Saves time
Ready-to-implant
Insures controlled product release over time
Avoids "peak and valley" effects
Guarantees consistent product preparation
Extends product life against spontaneous breakdown
Extends product life against host-related breakdown
Minimizes experimental variables
Insures safety of the experimenter
Reduces neurophysiological trauma to animal/no excessive handling
Generates more meaningful and reproducible results
Superior to conventional delivery methods
Enhances experimental efficiency
Frees valuable time for creative research
Saves money
Innovative Research of America的主要产品包括:
ANTIBIOTICS
ANTI-INFLAMMATORY AGENTS
ANTI-NEOPLASTICS
CATECHOLAMINES & RELATED PRODUCTS
CORTICOIDS & DIURETICS
ESTROGENS & ANTI-ESTROGENS
FATTY ACIDS
MISCELLANEOUS PRODUCTS
NUCLEOTIDE RELATED PRODUCTS
PLACEBO
PROGESTINS
PROSTAGLANDINS
THYROIDS
VITAMINS
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://plant.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Innovative Research of America"> Innovative Research of America
invivoCrown IV0120替换BioXCell BE0015-1
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:17754422825
传真:18771149750
邮箱:sales@amyjet.com
0.1484